APA (7th ed.) Citation

Q, L., L, J., PQ, W., LY, H., HY, X., & CL, H. (2024). [Clinical Efficacy and Safety of Flumatinib in the Treatment of Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase]. Zhongguo shi yan xue ye xue za zhi, 32(1), 14. https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.01.003

Chicago Style (17th ed.) Citation

Q, Li, Jing L, Wu PQ, Han LY, Xing HY, and Huang CL. "[Clinical Efficacy and Safety of Flumatinib in the Treatment of Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase]." Zhongguo Shi Yan Xue Ye Xue Za Zhi 32, no. 1 (2024): 14. https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.01.003.

MLA (9th ed.) Citation

Q, Li, et al. "[Clinical Efficacy and Safety of Flumatinib in the Treatment of Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase]." Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 32, no. 1, 2024, p. 14, https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.01.003.